CN Stock MarketDetailed Quotes

300683 Wuhan Hiteck Biological Pharma

Watchlist
  • 25.90
  • +0.15+0.58%
Trading Oct 24 11:00 CST
3.39BMarket Cap-25268P/E (TTM)

Wuhan Hiteck Biological Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
2.87%450.99M
-0.64%284.62M
-4.87%131.89M
-12.54%602.28M
-19.80%438.43M
-26.03%286.45M
-16.59%138.64M
12.03%688.63M
39.32%546.64M
71.69%387.23M
Operating revenue
2.87%450.99M
-0.64%284.62M
-4.87%131.89M
-12.54%602.28M
-19.80%438.43M
-26.03%286.45M
-16.59%138.64M
12.03%688.63M
39.32%546.64M
71.69%387.23M
Other operating revenue
----
-46.91%4.78M
----
-1.04%7.8M
----
197.16%9M
----
21.59%7.89M
----
-17.54%3.03M
Total operating cost
5.37%533.19M
3.46%341.12M
20.19%185.59M
3.34%714.28M
-4.78%506.04M
-8.91%329.72M
-4.45%154.42M
14.83%691.22M
42.52%531.42M
66.08%361.96M
Operating cost
0.92%246.97M
-6.28%154.34M
1.67%79.25M
-2.77%345.06M
-14.42%244.73M
-19.26%164.68M
-6.43%77.95M
34.02%354.88M
110.45%285.96M
190.40%203.97M
Operating tax surcharges
28.80%5.04M
23.65%3.38M
23.93%1.42M
-2.96%5.47M
-3.49%3.91M
-0.65%2.73M
-4.12%1.15M
58.69%5.64M
43.63%4.05M
17.04%2.75M
Operating expense
0.84%100.16M
-5.13%64.06M
-11.48%27.79M
1.55%128.66M
2.63%99.32M
14.04%67.53M
1.64%31.4M
-13.02%126.71M
-6.06%96.78M
-9.27%59.21M
Administration expense
30.18%95.13M
28.27%62.11M
114.77%49.44M
20.80%113.33M
7.49%73.08M
8.18%48.42M
15.88%23.02M
-3.58%93.81M
0.95%67.99M
1.94%44.76M
Financial expense
45.43%-3.14M
63.66%-1.73M
92.64%-241.53K
36.51%-7.14M
34.95%-5.75M
25.64%-4.77M
3.32%-3.28M
10.32%-11.25M
3.29%-8.83M
2.64%-6.41M
-Interest expense (Financial expense)
19.42%2.05M
29.68%1.41M
222.14%1.19M
114.35%2.39M
47.68%1.72M
11.54%1.09M
-28.95%369.05K
124.92%1.12M
259.82%1.16M
506.81%976.19K
-Interest Income (Financial expense)
27.97%-5.61M
42.13%-3.53M
57.45%-1.62M
22.29%-9.99M
24.79%-7.79M
18.35%-6.11M
5.69%-3.8M
5.45%-12.86M
-5.76%-10.36M
-6.48%-7.48M
Research and development
-1.88%89.03M
15.33%58.97M
15.47%27.94M
6.15%128.9M
6.16%90.74M
-11.37%51.13M
-18.70%24.2M
17.71%121.43M
17.20%85.47M
34.87%57.69M
Credit Impairment Loss
-84.99%324.45K
-65.49%722.16K
-40.39%564.6K
74.31%-974.97K
9,122.68%2.16M
253.44%2.09M
122.90%947.22K
-115.97%-3.79M
100.17%23.43K
88.08%-1.36M
Asset Impairment Loss
-198.90%-1.67M
-145.44%-1.41M
370.69%17.7M
-81.03%-60.12M
118.76%1.69M
148.90%3.11M
--3.76M
-183.99%-33.21M
-17.79%-8.99M
-28.90%-6.36M
Other net revenue
34.08%32.9M
35.29%27.71M
179.60%25.81M
-635.32%-31.08M
276.72%24.53M
1,327.85%20.48M
651.66%9.23M
-149.24%-4.23M
196.46%6.51M
123.24%1.43M
Fair value change income
-60.34%4.62M
-10.43%6.1M
149.25%5.81M
-85.02%1.9M
241.85%11.65M
1,143.19%6.81M
-10.20%2.33M
3,903.39%12.67M
335.88%3.41M
38.08%-653.22K
Invest income
152.12%7.53M
90.13%4.08M
10,050.76%239.11K
42.06%15.69M
-44.36%2.99M
-63.66%2.15M
-98.48%2.36K
-23.00%11.04M
-47.12%5.37M
-29.83%5.91M
-Including: Investment income associates
----
----
----
-15.16%-2.77M
----
----
----
-9,453.53%-2.4M
----
----
Asset deal income
97.93%-45.09K
-210.95%-43.5K
-210.95%-43.5K
-282.04%-358.67K
-828.31%-2.18M
143.06%39.21K
--39.21K
48.12%-93.88K
684.93%299.27K
-85.71%-91.05K
Other revenue
168.98%22.13M
190.92%18.26M
-28.26%1.54M
39.69%12.79M
28.58%8.23M
57.06%6.28M
-17.65%2.15M
11.53%9.16M
8.67%6.4M
38.16%4M
Operating profit
-14.47%-49.31M
-26.34%-28.79M
-325.78%-27.89M
-1,997.07%-143.07M
-298.19%-43.07M
-185.32%-22.78M
-212.60%-6.55M
-131.97%-6.82M
70.47%21.73M
1,762.08%26.71M
Add:Non operating Income
82.57%222.45K
-70.62%32.95K
-96.16%3.75K
-59.40%172.06K
-43.20%121.85K
-32.71%112.15K
-96.69%97.53K
-28.81%423.83K
-62.53%214.51K
-19.48%166.67K
Less:Non operating expense
-60.54%2.45M
-64.98%716.34K
54.39%559.25K
537.43%9.09M
697.99%6.22M
265.72%2.05M
59.65%362.23K
-3.65%1.43M
-16.04%779.56K
-17.20%559.31K
Total profit
-4.81%-51.54M
-19.22%-29.47M
-317.39%-28.45M
-1,842.57%-151.99M
-332.29%-49.17M
-193.94%-24.72M
-179.82%-6.82M
-138.25%-7.82M
70.81%21.17M
2,624.82%26.31M
Less:Income tax cost
52.24%-9.34M
57.73%-5.03M
-114.80%-10.95M
-32,106.33%-23.74M
-453.74%-19.56M
-1,228.50%-11.9M
-228.44%-5.1M
100.78%74.18K
47.02%-3.53M
121.39%1.05M
Net profit
FPtoL-42.2M
FPtoL-24.44M
FPtoL-17.49M
FPtoL-128.24M
SL-29.62M
SL-12.82M
SL-1.72M
SL-7.9M
29.60%24.7M
328.48%25.26M
Net profit from continuing operation
-42.48%-42.2M
-90.68%-24.44M
-919.75%-17.49M
-1,523.72%-128.24M
-219.90%-29.62M
-150.74%-12.82M
-117.00%-1.72M
-126.31%-7.9M
29.60%24.7M
328.48%25.26M
Less:Minority Profit
22.73%-2.45M
0.90%-1.67M
-288.92%-946.15K
-221.02%-7.42M
-154.04%-3.18M
-126.45%-1.69M
-110.14%-243.28K
159.73%6.13M
1,289.40%5.88M
583.12%6.39M
Net profit of parent company owners
-50.32%-39.74M
-104.58%-22.77M
-1,024.00%-16.55M
-761.20%-120.82M
-240.47%-26.44M
-158.96%-11.13M
-119.14%-1.47M
-150.73%-14.03M
1.00%18.82M
161.49%18.87M
Earning per share
Basic earning per share
-42.86%-0.3
-88.89%-0.17
-550.00%-0.13
-745.45%-0.93
-240.00%-0.21
-160.00%-0.09
-133.33%-0.02
-142.31%-0.11
-16.67%0.15
114.29%0.15
Diluted earning per share
-42.86%-0.3
-88.89%-0.17
-550.00%-0.13
-745.45%-0.93
-240.00%-0.21
-160.00%-0.09
-133.33%-0.02
-142.31%-0.11
-16.67%0.15
114.29%0.15
Other composite income
Total composite income
-42.48%-42.2M
-90.68%-24.44M
-919.75%-17.49M
-1,523.72%-128.24M
-219.90%-29.62M
-150.74%-12.82M
-117.00%-1.72M
-126.31%-7.9M
29.60%24.7M
328.48%25.26M
Total composite income of parent company owners
-50.32%-39.74M
-104.58%-22.77M
-1,024.00%-16.55M
-761.20%-120.82M
-240.47%-26.44M
-158.96%-11.13M
-119.14%-1.47M
-150.73%-14.03M
1.00%18.82M
161.49%18.87M
Total composite income of minority owners
22.73%-2.45M
0.90%-1.67M
-288.92%-946.15K
-221.02%-7.42M
-154.04%-3.18M
-126.45%-1.69M
-110.14%-243.28K
159.73%6.13M
1,289.40%5.88M
583.12%6.39M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
China Audit Zhonghuan Certified Public Accountants (Special General Partnership)
--
--
--
China Audit Zhonghuan Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 2.87%450.99M-0.64%284.62M-4.87%131.89M-12.54%602.28M-19.80%438.43M-26.03%286.45M-16.59%138.64M12.03%688.63M39.32%546.64M71.69%387.23M
Operating revenue 2.87%450.99M-0.64%284.62M-4.87%131.89M-12.54%602.28M-19.80%438.43M-26.03%286.45M-16.59%138.64M12.03%688.63M39.32%546.64M71.69%387.23M
Other operating revenue -----46.91%4.78M-----1.04%7.8M----197.16%9M----21.59%7.89M-----17.54%3.03M
Total operating cost 5.37%533.19M3.46%341.12M20.19%185.59M3.34%714.28M-4.78%506.04M-8.91%329.72M-4.45%154.42M14.83%691.22M42.52%531.42M66.08%361.96M
Operating cost 0.92%246.97M-6.28%154.34M1.67%79.25M-2.77%345.06M-14.42%244.73M-19.26%164.68M-6.43%77.95M34.02%354.88M110.45%285.96M190.40%203.97M
Operating tax surcharges 28.80%5.04M23.65%3.38M23.93%1.42M-2.96%5.47M-3.49%3.91M-0.65%2.73M-4.12%1.15M58.69%5.64M43.63%4.05M17.04%2.75M
Operating expense 0.84%100.16M-5.13%64.06M-11.48%27.79M1.55%128.66M2.63%99.32M14.04%67.53M1.64%31.4M-13.02%126.71M-6.06%96.78M-9.27%59.21M
Administration expense 30.18%95.13M28.27%62.11M114.77%49.44M20.80%113.33M7.49%73.08M8.18%48.42M15.88%23.02M-3.58%93.81M0.95%67.99M1.94%44.76M
Financial expense 45.43%-3.14M63.66%-1.73M92.64%-241.53K36.51%-7.14M34.95%-5.75M25.64%-4.77M3.32%-3.28M10.32%-11.25M3.29%-8.83M2.64%-6.41M
-Interest expense (Financial expense) 19.42%2.05M29.68%1.41M222.14%1.19M114.35%2.39M47.68%1.72M11.54%1.09M-28.95%369.05K124.92%1.12M259.82%1.16M506.81%976.19K
-Interest Income (Financial expense) 27.97%-5.61M42.13%-3.53M57.45%-1.62M22.29%-9.99M24.79%-7.79M18.35%-6.11M5.69%-3.8M5.45%-12.86M-5.76%-10.36M-6.48%-7.48M
Research and development -1.88%89.03M15.33%58.97M15.47%27.94M6.15%128.9M6.16%90.74M-11.37%51.13M-18.70%24.2M17.71%121.43M17.20%85.47M34.87%57.69M
Credit Impairment Loss -84.99%324.45K-65.49%722.16K-40.39%564.6K74.31%-974.97K9,122.68%2.16M253.44%2.09M122.90%947.22K-115.97%-3.79M100.17%23.43K88.08%-1.36M
Asset Impairment Loss -198.90%-1.67M-145.44%-1.41M370.69%17.7M-81.03%-60.12M118.76%1.69M148.90%3.11M--3.76M-183.99%-33.21M-17.79%-8.99M-28.90%-6.36M
Other net revenue 34.08%32.9M35.29%27.71M179.60%25.81M-635.32%-31.08M276.72%24.53M1,327.85%20.48M651.66%9.23M-149.24%-4.23M196.46%6.51M123.24%1.43M
Fair value change income -60.34%4.62M-10.43%6.1M149.25%5.81M-85.02%1.9M241.85%11.65M1,143.19%6.81M-10.20%2.33M3,903.39%12.67M335.88%3.41M38.08%-653.22K
Invest income 152.12%7.53M90.13%4.08M10,050.76%239.11K42.06%15.69M-44.36%2.99M-63.66%2.15M-98.48%2.36K-23.00%11.04M-47.12%5.37M-29.83%5.91M
-Including: Investment income associates -------------15.16%-2.77M-------------9,453.53%-2.4M--------
Asset deal income 97.93%-45.09K-210.95%-43.5K-210.95%-43.5K-282.04%-358.67K-828.31%-2.18M143.06%39.21K--39.21K48.12%-93.88K684.93%299.27K-85.71%-91.05K
Other revenue 168.98%22.13M190.92%18.26M-28.26%1.54M39.69%12.79M28.58%8.23M57.06%6.28M-17.65%2.15M11.53%9.16M8.67%6.4M38.16%4M
Operating profit -14.47%-49.31M-26.34%-28.79M-325.78%-27.89M-1,997.07%-143.07M-298.19%-43.07M-185.32%-22.78M-212.60%-6.55M-131.97%-6.82M70.47%21.73M1,762.08%26.71M
Add:Non operating Income 82.57%222.45K-70.62%32.95K-96.16%3.75K-59.40%172.06K-43.20%121.85K-32.71%112.15K-96.69%97.53K-28.81%423.83K-62.53%214.51K-19.48%166.67K
Less:Non operating expense -60.54%2.45M-64.98%716.34K54.39%559.25K537.43%9.09M697.99%6.22M265.72%2.05M59.65%362.23K-3.65%1.43M-16.04%779.56K-17.20%559.31K
Total profit -4.81%-51.54M-19.22%-29.47M-317.39%-28.45M-1,842.57%-151.99M-332.29%-49.17M-193.94%-24.72M-179.82%-6.82M-138.25%-7.82M70.81%21.17M2,624.82%26.31M
Less:Income tax cost 52.24%-9.34M57.73%-5.03M-114.80%-10.95M-32,106.33%-23.74M-453.74%-19.56M-1,228.50%-11.9M-228.44%-5.1M100.78%74.18K47.02%-3.53M121.39%1.05M
Net profit FPtoL-42.2MFPtoL-24.44MFPtoL-17.49MFPtoL-128.24MSL-29.62MSL-12.82MSL-1.72MSL-7.9M29.60%24.7M328.48%25.26M
Net profit from continuing operation -42.48%-42.2M-90.68%-24.44M-919.75%-17.49M-1,523.72%-128.24M-219.90%-29.62M-150.74%-12.82M-117.00%-1.72M-126.31%-7.9M29.60%24.7M328.48%25.26M
Less:Minority Profit 22.73%-2.45M0.90%-1.67M-288.92%-946.15K-221.02%-7.42M-154.04%-3.18M-126.45%-1.69M-110.14%-243.28K159.73%6.13M1,289.40%5.88M583.12%6.39M
Net profit of parent company owners -50.32%-39.74M-104.58%-22.77M-1,024.00%-16.55M-761.20%-120.82M-240.47%-26.44M-158.96%-11.13M-119.14%-1.47M-150.73%-14.03M1.00%18.82M161.49%18.87M
Earning per share
Basic earning per share -42.86%-0.3-88.89%-0.17-550.00%-0.13-745.45%-0.93-240.00%-0.21-160.00%-0.09-133.33%-0.02-142.31%-0.11-16.67%0.15114.29%0.15
Diluted earning per share -42.86%-0.3-88.89%-0.17-550.00%-0.13-745.45%-0.93-240.00%-0.21-160.00%-0.09-133.33%-0.02-142.31%-0.11-16.67%0.15114.29%0.15
Other composite income
Total composite income -42.48%-42.2M-90.68%-24.44M-919.75%-17.49M-1,523.72%-128.24M-219.90%-29.62M-150.74%-12.82M-117.00%-1.72M-126.31%-7.9M29.60%24.7M328.48%25.26M
Total composite income of parent company owners -50.32%-39.74M-104.58%-22.77M-1,024.00%-16.55M-761.20%-120.82M-240.47%-26.44M-158.96%-11.13M-119.14%-1.47M-150.73%-14.03M1.00%18.82M161.49%18.87M
Total composite income of minority owners 22.73%-2.45M0.90%-1.67M-288.92%-946.15K-221.02%-7.42M-154.04%-3.18M-126.45%-1.69M-110.14%-243.28K159.73%6.13M1,289.40%5.88M583.12%6.39M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------China Audit Zhonghuan Certified Public Accountants (Special General Partnership)------China Audit Zhonghuan Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data